CSP. V7.0 First-in-human clinical study with RNA-Immunotherapy combination of IVAC_W_bre1_uID and IVAC_M_uID for Individualized Tumor Therapy in Triple Negative Breast Cancer Patients
Appears in 2 contracts
Samples: Collaboration Agreement (BioNTech SE), Collaboration Agreement (BioNTech SE)
CSP. V7.0 V6.0 First-in-human clinical study with RNA-Immunotherapy combination of IVAC_W_bre1_uID and IVAC_M_uID for Individualized Tumor Therapy in Triple Negative Breast Cancer Patients
Appears in 2 contracts
Samples: Collaboration Agreement (BioNTech SE), Collaboration Agreement (BioNTech SE)
